VENEETUBMANVENEE TUBMAN12704TUBMAN, VENEEAssistant Professorplugins:FeaturedVideosFeatured Videosplugins:TwitterTwitterprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:orcidIdORCID idvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonLeukemiaPalliative Care & Rehabilitation MedicineMD AndersonHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorEDUARDOBRUERAEDUARDO BRUERA8804BRUERA, EDUARDOProfessorNICHOLASETTINGERNICHOLAS ETTINGER10854ETTINGER, NICHOLAS0000-0002-0388-769Adjunct Associate ProfessorHYOJEONGHANHYOJEONG HAN11380HAN, HYOJEONGAssistant Professor74Professor10Assistant Professor54Instructor3Adjunct Associate Professor26292080Green AL, Yi J, Bezler N, Pikman Y, Tubman VN, Obeng EA, O'Neil T, Mersereau R, Morrissey L, Billett ALPediatric blood & cancerA Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients. Pediatr Blood Cancer. 2016 Jan; 63(1):112-7.Pediatr Blood Cancer2015-08-20T00:00:002015A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients.1102 BATESHouston, 77030TX7.840590.00660037163research areas0.9378710.05936718coauthor of48.24165.8605260similar to1127selected publicationstrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant ProfessorD000765Procedures33420.940335Anesthesia, ConductionAuthorship 8908232Authorship 8908246Authorship 8908258Authorship 8908262Authorship 8908278Authorship 89082810Authorship 8908298Authorship 8908308Authorship 8908312Authorship 8908325Authorship 8908337Authorship 890834328493472Tubman VN, Makani JBritish journal of haematologyTurf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions. Br J Haematol. 2017 06; 177(6):938-946.Br J Haematol2017-05-11T00:00:002017Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.27232273Koegel AK, Hofmann I, Moffitt K, Degar B, Duncan C, Tubman VNPediatric blood & cancerAcute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency. Pediatr Blood Cancer. 2016 10; 63(10):1844-7.Pediatr Blood Cancer2016-05-27T00:00:002016Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency.26739520Tubman VN, Marshall R, Jallah W, Guo D, Ma C, Ohene-Frempong K, London WB, Heeney MMPediatric blood & cancerNewborn Screening for Sickle Cell Disease in Liberia: A Pilot Study. Pediatr Blood Cancer. 2016 Apr; 63(4):671-6.Pediatr Blood Cancer2016-01-06T00:00:002016Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.26637754Tubman VN, Field JJHematology. American Society of Hematology. Education ProgramSickle solubility test to screen for sickle cell trait: what's the harm? Hematology Am Soc Hematol Educ Program. 2015; 2015:433-5.Hematology Am Soc Hematol Educ Program2015-01-01T00:00:002015Sickle solubility test to screen for sickle cell trait: what's the harm?26459896Tubman VN, Mejia P, Shmukler BE, Bei AK, Alper SL, Mitchell JR, Brugnara C, Duraisingh MTAntimicrobial agents and chemotherapyThe Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity. Antimicrob Agents Chemother. 2016 01; 60(1):613-6.Antimicrob Agents Chemother2015-10-12T00:00:002015The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.26201037Tubman VN, Fung EB, Vogiatzi M, Thompson AA, Rogers ZR, Neufeld EJ, Kwiatkowski JL, Thalassemia Clinical Research NetworkJournal of pediatric hematology/oncologyGuidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort. J Pediatr Hematol Oncol. 2015 Apr; 37(3):e162-9.J Pediatr Hematol Oncol2015-04-01T00:00:002015Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.27335926McQuilkin P, Marshall RE, Niescierenko M, Tubman VN, Olson BG, Staton D, Williams JH, Graham EAGlobal pediatric healthA Successful US Academic Collaborative Supporting Medical Education in a Postconflict Setting. Glob Pediatr Health. 2014; 1:2333794X14563383.Glob Pediatr Health2014-12-16T00:00:002014A Successful US Academic Collaborative Supporting Medical Education in a Postconflict Setting.24123084Tubman VN, Archer NMAmerican journal of hematologyBuilding partnerships to target sickle cell anemia in Africa. Am J Hematol. 2013 Dec; 88(12):983.Am J Hematol2013-12-01T00:00:002013Building partnerships to target sickle cell anemia in Africa.17551985Tubman VN, Bennett CM, Luo HY, Chui DH, Heeney MMPediatric blood & cancerSickle cell disease caused by Hb S/Qu?bec-CHORI: treatment with hydroxyurea and response. Pediatr Blood Cancer. 2007 Aug; 49(2):207-10.Pediatr Blood Cancer2007-08-01T00:00:002007Sickle cell disease caused by Hb S/Qu?bec-CHORI: treatment with hydroxyurea and response.17209061Tubman VN, Levine JE, Campagna DR, Monahan-Earley R, Dvorak AM, Neufeld EJ, Fleming MDBloodX-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation. Blood. 2007 Apr 15; 109(8):3297-9.Blood2007-01-05T00:00:002007X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.16435382Tubman VN, Smoot L, Heeney MMPediatric blood & cancerAcquired immune cytopenias post-cardiac transplantation respond to rituximab. Pediatr Blood Cancer. 2007 Mar; 48(3):339-44.Pediatr Blood Cancer2007-03-01T00:00:002007Acquired immune cytopenias post-cardiac transplantation respond to rituximab.true1Assistant ProfessorAssistant ProfessorD005334Disorders3024940.779183FeverD000755Disorders1673380.742872Anemia, Sickle CellD006402Disorders1582420.871952Hematologic DiseasesD015997Procedures711650.866864Neonatal ScreeningDepartment of PediatricsPediatrics-Academic GeneralPediatrics-Critical CarePediatrics-HematologyPediatrics-Hematology & OncologyBaylor College of MedicineJEANRAPHAELJEAN RAPHAEL0.000000000000000.000000000000001147RAPHAEL, JEANProfessorJONATHANFLANAGANJONATHAN FLANAGAN0.000000000000000.000000000000003971FLANAGAN, JONATHANAssistant ProfessorGLADSTONEAIREWELEGLADSTONE AIREWELE0.000000000000000.000000000000003478AIREWELE, GLADSTONEProfessorTITILOPEFASIPETITILOPE FASIPE0.000000000000000.000000000000006021FASIPE, TITILOPEAssistant ProfessorAuthorship 9934993Authorship 9935001Authorship 993501432043441Coria AL, Taylor CM, Tubman VNThe American journal of tropical medicine and hygieneFever Management in Sickle Cell Disease in Low- and Middle-Income Countries: A Survey of SCD Management Programs. Am J Trop Med Hyg. 2020 04; 102(4):902-904.Am J Trop Med Hyg2020-04-01T00:00:002020Fever Management in Sickle Cell Disease in Low- and Middle-Income Countries: A Survey of SCD Management Programs.31724295Tubman VNPediatric blood & cancerMother knows best: The caregiver's perspective on clinical trials for sickle cell disease highlights the challenges of providing care in Africa. Pediatr Blood Cancer. 2020 02; 67(2):e28054.Pediatr Blood Cancer2019-11-13T00:00:002019Mother knows best: The caregiver's perspective on clinical trials for sickle cell disease highlights the challenges of providing care in Africa.31347415Tripodi SI, Shamberger RC, Heeney MM, Tubman VNPediatric hematology and oncologyClinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis. Pediatr Hematol Oncol. 2019 Sep; 36(6):382-389.Pediatr Hematol Oncol2019-07-26T00:00:002019Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis.https://www.bcm.edu/departments/pediatrics/divisions-and-centers/critical-care-medicine/education/pediatric-critical-care-medicine-fellowshipBCM Division of Pediatric Critical Carehttp://www.texaschildrens.org/policycenterCenter for Child Health Policy and Advocacyhttp://www.texaschildrens.org/departments/critical-careTexas Children's Hospital PICUhttp://www.ncbi.nlm.nih.gov/sites/myncbi/1JQ96hdQp9oA8/bibliography/48962006/public/?sort=date&direction=ascendingComplete List of Published Work in MyBibliographyhttps://twitter.com/HawkeyeNickmd33689292Natoli ME, Chang MM, Kundrod KA, Coole JB, Airewele GE, Tubman VN, Richards-Kortum RRAnalytical chemistryAllele-Specific Recombinase Polymerase Amplification to Detect Sickle Cell Disease in Low-Resource Settings. Anal Chem. 2021 03 23; 93(11):4832-4840.Anal Chem2021-03-10T00:00:002021Allele-Specific Recombinase Polymerase Amplification to Detect Sickle Cell Disease in Low-Resource Settings.Authorship 1026036734889416Han H, Hensch L, Tubman VNHematology. American Society of Hematology. Education ProgramIndications for transfusion in the management of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):696-703.Hematology Am Soc Hematol Educ Program2021-12-10T00:00:002021Indications for transfusion in the management of sickle cell disease.true1ProfessorProfessorAuthorship 10369781231199090Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J, HOPE Trial InvestigatorsThe New England journal of medicineA Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.N Engl J Med2019-06-14T00:00:002019A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.Authorship 1038059535264367Archer NM, Inusa B, Makani J, Nkya S, Tshilolo L, Tubman VN, McGann PT, Ambrose EE, Henrich N, Spector J, Ohene-Frempong KBMJ openEnablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries. BMJ Open. 2022 03 09; 12(3):e057623.BMJ Open2022-03-09T00:00:002022Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries.35373913Karsenty C, Tubman VN, Liu CJ, Fasipe T, Wyatt KEKPediatric blood & cancerRegional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series. Pediatr Blood Cancer. 2022 06; 69(6):e29695.Pediatr Blood Cancer2022-04-04T00:00:002022Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series.Authorship 10490035Authorship 1049004336206076John TD, Namazzi R, Chirande L, Tubman VNCurrent opinion in hematologyGlobal perspectives on cellular therapy for children with sickle cell disease. Curr Opin Hematol. 2022 11 01; 29(6):275-280.Curr Opin Hematol2022-09-21T00:00:002022Global perspectives on cellular therapy for children with sickle cell disease.37014836Udhayashankar K, Franklin PD, Nuta CJ, Cherue AK, Haq H, Thompson D, Tubman VNPLOS global public healthDeterminants of retention in care of newborns diagnosed with sickle cell disease in Liberia: Results from a mixed-methods study of caregivers. PLOS Glob Public Health. 2023; 3(4):e0001705.PLOS Glob Public Health2023-04-04T00:00:002023Determinants of retention in care of newborns diagnosed with sickle cell disease in Liberia: Results from a mixed-methods study of caregivers.37185357Ettinger NA, Guffey D, Anum SJ, Fasipe T, Katkin J, Bhar S, Airewele G, Saini A, Tubman VNScientific reportsMulti-center retrospective study of children with sickle cell disease admitted to pediatric intensive care units in the United States. Sci Rep. 2023 04 25; 13(1):6758.Sci Rep2023-04-25T00:00:002023Multi-center retrospective study of children with sickle cell disease admitted to pediatric intensive care units in the United States.CECILEKARSENTYCECILE KARSENTY18927KARSENTY, CECILEInstructortrue1InstructorInstructorAuthorship 10764403Authorship 10764419Authorship 10764427Authorship 10764435Authorship 1076444436264096Green NS, Zapfel A, Nnodu OE, Franklin P, Tubman VN, Chirande LF, Kiyaga C, Chunda-Liyoka CM, Awuonda B, Ohene-Frempong K, Inusa BP, Ware RE, Odame I, Ambrose EE, Dogara LG, Oron AP, Willett C, Thompson AA, Berliner N, Coetzer TL, Novelli EMBlood advancesThe consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology. Blood Adv. 2022 Oct 20.Blood Adv2022-10-20T00:00:002022The consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology.37216689Tubman VN, Mohandas N, Abrams CSBloodNew ASH initiatives to improve patient care in the long-overlooked sickle cell disease. Blood. 2023 07 20; 142(3):230-234.Blood2023-07-20T00:00:002023New ASH initiatives to improve patient care in the long-overlooked sickle cell disease.37625829Poventud-Fuentes I, Portillo TP, Olayinka L, Marcogliese AN, Tubman VN, Devaraj SAnnals of clinical and laboratory scienceUnique Hemoglobinopathy Pattern Following Treatment with Voxelotor. Ann Clin Lab Sci. 2023 Jul; 53(4):647-652.Ann Clin Lab Sci2023-07-01T00:00:002023Unique Hemoglobinopathy Pattern Following Treatment with Voxelotor.true1Adjunct Associate ProfessorAdjunct Associate Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor38000561Onyebuchi CO, Chumpitazi CE, Placencia JL, Jackson AN, Jones JL, Torres L, Tubman VNJournal of pain and symptom managementKetamine for Pain in Sickle Cell Disease Reduces Opioid Usage. J Pain Symptom Manage. 2024 Mar; 67(3):e169-e175.J Pain Symptom Manage2023-11-23T00:00:002023Ketamine for Pain in Sickle Cell Disease Reduces Opioid Usage.Authorship 108579414Authorship 10857955true1ProfessorProfessortrue1ProfessorProfessor